Search Results

You are looking at 1 - 10 of 33 items for :

  • "papillary thyroid carcinoma" x
  • All content x
Clear All
Free access

Chen-Tian Shen, Wei-Jun Wei, Zhong-Ling Qiu, Hong-Jun Song, Xin-Yun Zhang, Zhen-Kui Sun, and Quan-Yong Luo

papillary thyroid carcinoma cell lines BCPAP (DSMZ, German Collection of Microorganisms and Cell Cultures) and KTC1 (kindly provided by Stem Cell Bank, Chinese Academy of Sciences, Shanghai, China) were cultured in RPMI-1640 supplemented with 10% fetal

Restricted access

Ting Yan, Wangwang Qiu, Jianlu Song, Youben Fan, and Zhili Yang

Introduction Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy, accounting for 85% of all thyroid cancers, with a growing incidence rate every year ( Siegelr et al. 2020 ). The diagnosis of PTC has benefited

Free access

Xiaoqi Lin, Sydney D Finkelstein, Bing Zhu, and Jan F Silverman

Introduction Papillary thyroid carcinoma (PTC) is the most common malignancy ( Harach et al . 1985 , Sakorafas et al . 2005 ). It is considered to be a relatively indolent malignancy in which distant metastasis and death from disease are uncommon

Restricted access

Yujia Pan, Weikang Yun, Bingshuai Shi, Rongjun Cui, Chi Liu, Zhong Ding, Jialin Fan, Wenqian Jiang, Jiebing Tang, Tianhu Zheng, Xiaoguang Yu, and Ying Liu

clinicopathological characteristics of papillary thyroid carcinoma patients. Characteristics Number Iodine areas P value High Adequate Gender  Male 9 4 5 0.653  Female 11 6 5 Age

Free access

Sonia D'Inzeo, Arianna Nicolussi, Antonella Ricci, Patrizia Mancini, Antonio Porcellini, Francesco Nardi, and Anna Coppa

in a group of 23 cases of human papillary thyroid carcinomas (PTCs). Our data demonstrated for the first time that these cells showed a strong reduction in the level of SMAD4 protein, which was responsible for an alteration of TGFβ signaling and for

Free access

E Mato, C González, A Moral, J I Pérez, O Bell, E Lerma, and A de Leiva

considered as biomarkers of poor prognosis for papillary thyroid carcinoma. In summary, we found that the expression of the ABCG2 / BCRP gene was associated with ZEB1 and other EMT-inducer genes involved in papillary thyroid tumor dedifferentiation. These

Free access

Ali Salajegheh, Haleh Vosgha, Atiqur Md Rahman, Moein Amin, Robert Anthony Smith, and Alfred King-Yin Lam

Tissue samples One hundred and one thyroid carcinomas consisting of 51 conventional papillary thyroid carcinomas (CPTCs), including 25 metastatic CPTC (CPTC LN+) and 26 non-metastatic (CPTC LN−), 37 follicular variant of papillary thyroid carcinoma (FVPTC

Free access

Luca Mologni, Elisa Sala, Sara Cazzaniga, Roberta Rostagno, Thomas Kuoni, Miriam Puttini, Jenny Bain, Loredana Cleris, Sara Redaelli, Barbara Riva, Franca Formelli, Leonardo Scapozza, and Carlo Gambacorti-Passerini

Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-( t -butyl)pyrazolo[3,4-d]pyrimidine (PP2). Journal of Clinical Endocrinology and Metabolism 88 1897 –1902. Carlomagno

Free access

Dagmara Rusinek, Sylwia Szpak-Ulczok, and Barbara Jarzab

. 2008 ) is among the highly upregulated genes in papillary thyroid carcinomas induced by the BRAF V600E mutation, and its over-expression in thyroid neoplasms ( Yano et al . 2004 ) and its presence in other tumors ( Terrile et al . 2010 ) have been

Free access

Matthias S Dettmer, Aurel Perren, Holger Moch, Paul Komminoth, Yuri E Nikiforov, and Marina N Nikiforova

for FTC, oncocytic FTC (oFTC) and follicular variant of papillary thyroid carcinoma (FVPTC) ( Dettmer et al . 2013 a , b ). Finally, we evaluated the clinical relevance of deregulated novel candidate miRNAs and assessed their prognostic value